4//SEC Filing
Kadia Siddhartha 4
Accession 0001209191-23-048185
CIK 0001142596other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:53 PM ET
Size
10.2 KB
Accession
0001209191-23-048185
Insider Transaction Report
Form 4
NUVASIVE INCNUVA
Kadia Siddhartha
Director
Transactions
- Disposition to Issuer
Restricted Stock Unit
2023-09-01−3,788→ 0 total→ Common Stock (3,788 underlying) - Disposition to Issuer
Common Stock, par value $0.001 per share
2023-09-01−3,739→ 0 total - Disposition to Issuer
Restricted Stock Unit
2023-09-01−4,816→ 0 total→ Common Stock (4,816 underlying)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus ("Globus Class A Common Stock"), par value $0.001 per share (the "Exchange Ratio" and such shares, the "Merger Consideration"), and cash in lieu of fractional shares.
- [F2]Represented a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award.
Documents
Issuer
NUVASIVE INC
CIK 0001142596
Entity typeother
Related Parties
1- filerCIK 0001573666
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:53 PM ET
- Size
- 10.2 KB